CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
January 2016—Worthington Biochemical announced distribution rights to the Celase GMP compliant enzyme from Cytori Therapeutics. The Celase GMP product offering allows Worthington customers focused on cell isolation studies to facilitate a smooth transition from bench and animal research to downstream clinical applications. Celase GMP is a proprietary enzyme containing a unique blend of collagenase, neutral protease, and buffer salts that are produced using avian and mammalian tissue-free raw materials and are aseptically processed, sterile filtered, and highly purified under GMP guidelines. A single, sterile, ready-to-use enzyme containing both collagenase and a neutral protease is suitable for a wide range of adipose stem cell, biomedical, and bioprocessing applications.
Worthington Biochemical , 732-942-1660